JAK2 V617F mutation, PRV-1 overexpression and endogenous erythroid colony formation show different coexpression patterns among Ph-negative chronic myeloproliferative disorders.
Bellosillo
B
B
Besses
C
C
Florensa
L
L
Solé
F
F
Serrano
S
S
D019943:Amino Acid Substitution; D002908:Chronic Disease; D003114:Colony-Forming Units Assay; D015672:Erythroid Precursor Cells / Q000473:pathology*; D058851:GPI-Linked Proteins; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007519:Isoantigens / Q000096:biosynthesis* / Q000235:genetics*; D053614:Janus Kinase 2; D008562:Membrane Glycoproteins / Q000096:biosynthesis* / Q000235:genetics*; D009154:Mutation; D009196:Myeloproliferative Disorders / Q000175:diagnosis / Q000235:genetics*; D010677:Philadelphia Chromosome; D011505:Protein-Tyrosine Kinases / Q000235:genetics*; D011518:Proto-Oncogene Proteins / Q000235:genetics*; D011956:Receptors, Cell Surface / Q000096:biosynthesis* / Q000235:genetics*
C407242:CD177 protein, human; D058851:GPI-Linked Proteins; D007519:Isoantigens; D008562:Membrane Glycoproteins; D011518:Proto-Oncogene Proteins; D011956:Receptors, Cell Surface; D011505:Protein-Tyrosine Kinases; C507924:JAK2 protein, human; D053614:Janus Kinase 2